The CPT code 43248 is frequently used for therapeutic upper endoscopy procedures completed to alleviate swallowing and esophageal obstruction caused by esophageal narrowing. Correct coding requires a clear description of the site of the stricture, the position of the guidewire, and the dilation method used during the procedure.
Esophageal dilation is a service that is often subject to medical necessity review, so it is important that details of the procedure and indications are well documented. Compliant reporting can help to mitigate the risk of therapeutic endoscopic interventions being denied as well as billable.
CPT 43248 Description
Official Definition:
"Esophagogastroduodenoscopy, flexible, transoral; with insertion of guide wire followed by passage of dilator(s) through esophagus over guidewire."
CPT 43248 describes a therapeutic upper gastrointestinal endoscopy in which a flexible endoscope is advanced through the mouth to evaluate the esophagus, stomach, and duodenum. After identifying an esophageal narrowing, a guidewire is placed across the stricture, and one or more dilators are passed over the guidewire to widen the narrowed segment.
This is often performed for complex and tight esophageal strictures where dilation is needed. The diagnostic portion of the EGD is not separately reportable.
The service includes
- Flexible transoral esophagogastroduodenoscopy (EGD)
- Evaluation of the esophagus, stomach, and duodenum
- Placement of a guidewire across the esophageal stricture
- Passage of one or more dilators over the guidewire
- Assessment of the dilation outcome
However, CPT 43248 does not include
- Separate reporting of the diagnostic EGD
- Balloon dilation of the esophagus
- Dilation of gastric or duodenal strictures
- Unbundling of included endoscopic services
Clinical Indications for CPT 43248
The code CPT 43248 is usually used when there is an esophageal stricture which is causing trouble with swallowing or blocking the passage of food down the esophagus. The procedure can aid to reopen the esophagus and relieve patient symptoms.
Typical indications include
- Benign esophageal strictures
- Peptic esophageal strictures
- Radiation-induced esophageal narrowing
- Anastomotic strictures
- Malignant esophageal strictures
- Eosinophilic esophagitis with the formation of a stricture.
- Swallowing problems due to narrowing in the oesophagus.
The procedure may also be performed when a clinically significant stricture is identified during diagnostic upper endoscopy and immediate dilation is medically appropriate.
Reimbursement Insights for CPT 43248
The reimbursement for CPT 43248 is not specific to any given procedure, but will depend upon the therapeutic nature of the procedure and medical necessity for esophageal dilation. Coverage is usually provided when the documentation is clear and establishes a diagnosis and indicates a need to have guidewire-assisted treatment.
Key reimbursement considerations
- Covered by Medicare and most commercial payers when medically necessary
- Reimbursement is generally higher than diagnostic EGD services
- Global period: 000 days
- When performing diagnostic EGD, this procedure is included in CPT 43248.
- Multiple dilators used in the same session are reported as one unit
- Payment may differ depending on geographic region, site of service and the type of payer.
- Hospital outpatient departments and ASCs may receive separate facility reimbursement
Applicable Modifiers for CPT 43248
Modifier selection should reflect the nature of the procedure and any other service(s) rendered during the encounter. Any modifiers must be supported by a rationale.
Common modifiers
- Modifier -22: Used when the procedure requires significantly greater effort than normally expected, such as treatment of a particularly difficult or complex stricture.
- Modifier -52: Used when the planned dilation service is reduced or only partially completed.
- Modifier -53: Used when the procedure is discontinued due to patient instability, technical limitations, or safety concerns.
- Modifier -59 or X{EPSU}: Used when a distinct procedural service is performed and separate reporting is supported by payer guidelines.
- Modifier -74: May be appropriate in facility settings when the procedure is discontinued after anesthesia administration.
Important billing rule:
CPT 43248 should be reported as the primary therapeutic service when guidewire-assisted esophageal dilation is performed. The diagnostic EGD should not be billed separately.
Documentation Requirements for CPT 43248
The procedure report should clearly state the characteristics of the stricture and describe the technique for dilation using the guidewire.
Documentation should include
- Medical indication for esophageal dilation
- Symptoms supporting treatment, such as dysphagia
- Location of the esophageal stricture
- Severity and characteristics of the narrowing
- Guidewire placement details
- Type of dilator used
- Size of dilator(s) utilized
- Number of dilation passes performed
- Post-dilation findings
- Any complications or procedural limitations
- Patient tolerance of the procedure
- Signed final procedure report
Clear documentation of the guidewire technique is important to distinguish CPT 43248 from other esophageal dilation codes.
Example Clinical Scenarios
Scenario 1: Peptic Esophageal Stricture Causing Dysphagia
A 65 year-old patient with chronic GERD comes in with gradual swallowing dysphagia for solid foods. A gastroenterologist finds a stricture in the distal esophagus during an upper endoscopy. A guidewire is inserted through the narrowing, then serial dilators are inserted over the guidewire to reopen the lumen.
→ Coding Outcome: CPT 43248
→ Rationale: Guidewire-assisted esophageal dilation was performed during EGD to treat an esophageal stricture.
Scenario 2: Radiation-Induced Esophageal Narrowing
A patient with a history of radiation therapy for head and neck cancer develops significant dysphagia. Upper endoscopy reveals a tight mid-esophageal stricture, and over-the-wire dilation is successfully performed.
→ Coding Outcome: CPT 43248
→ Rationale: EGDs performed to treat esophageal stricture with the use of guidewire to assist in esophageal dilation.
Scenario 3: Anastomotic Esophageal Stricture Following Surgery
One patient complains of a recurrence of swallowing difficulty after esophageal surgery. Anastomotic stricture is identified during endoscopic evaluation and the procedure is done via the guidewire-assisted method.
→ Coding Outcome: CPT 43248
→ Rationale: Therapeutic esophageal dilation of an esophageal stricture with the use of guidewire-assisted dilators fulfills the requirements of CPT 43248.
Scenario 4: Procedure Discontinued Due to Safety Concerns
A patient is being treated for a stricture in the oesophagus in a planned procedure. Once guidewire is placed, the physician decides that he would not risk a perforation if he were to further dilate for any more wire.
→ Coding Outcome: CPT 43248-53
→ Rationale: The procedure was not completed because it was deemed unsafe for the patient, which is why modifier -53 was used.
BillingFreedom Driving 97%+ First-Pass Claim Accuracy in GI Billing
BillingFreedom can assist you with the documentation and coding challenges of gastroenterology (GI) therapeutic endoscopic procedures. The reporting of esophageal dilation services often needs to be detailed and claims must be submitted in the correct manner with proper coding.
Our attention on documentation integrity for gastroenterology medical billing and coding accuracy will help practices enhance the quality of their claims prior to submission. This proactive approach will enhance billing workflow consistency and minimize claim disruption due to coding-related problems.
Key Revenue Cycle Performance Metrics
The billing processes used by BillingFreedom are focused on performance and efficiency to ensure higher reimbursement and uphold coding accuracy and compliance standards.
- First-pass claim acceptance rate has been consistently maintained at 97% - 99% which helps to resolve claims quicker.
- Preventable denial rate maintained at below 1%, helping protect practice revenue
- Clean claim submission accuracy exceeding 95%, improving payer acceptance rates
- Internal coding validation accuracy > 98%.
- Continuous quality review
This approach assists gastroenterology practices in maximizing their operational efficiency while maintaining certain standards of reimbursement outcomes.
For more details about our Gastroenterology medical billing services, please don't hesitate to contact us by email at info@billingfreedom.com or call us at +1 (855) 415-3472.
It is our top priority to give you financial peace of mind!
Related ICD-10-CM Codes
ICD-10-CM Codes
C15.3 - Malignant neoplasm of upper third of esophagus
C15.4 - Malignant neoplasm of middle third of esophagus
C15.5 - Malignant neoplasm of lower third of esophagus
C15.8 - Malignant neoplasm of overlapping sites of esophagus
C15.9 - Malignant neoplasm of esophagus, unspecified
C16.1 - Malignant neoplasm of fundus of stomach
C16.2 - Malignant neoplasm of body of stomach
C16.3 - Malignant neoplasm of pyloric antrum
C16.4 - Malignant neoplasm of pylorus
C16.5 - Malignant neoplasm of lesser curvature of stomach, unspecified
C16.6 - Malignant neoplasm of greater curvature of stomach, unspecified
C16.8 - Malignant neoplasm of overlapping sites of stomach
C16.9 - Malignant neoplasm of stomach, unspecified
C78.7 - Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.80 - Secondary malignant neoplasm of unspecified digestive organ
C78.89 - Secondary malignant neoplasm of other digestive organs
C7A.092 - Malignant carcinoid tumor of the stomach
D00.1 - Carcinoma in situ of esophagus
D00.2 - Carcinoma in situ of stomach
D13.0 - Benign neoplasm of esophagus
D13.1 - Benign neoplasm of stomach
D13.2 - Benign neoplasm of duodenum
D13.30 - Benign neoplasm of unspecified part of small intestine
D13.39 - Benign neoplasm of other parts of small intestine
D13.99 - Benign neoplasm of ill-defined sites within the digestive system
D37.1 - Neoplasm of uncertain behavior of stomach
D37.2 - Neoplasm of uncertain behavior of small intestine
D37.3 - Neoplasm of uncertain behavior of appendix
D37.4 - Neoplasm of uncertain behavior of colon
D37.5 - Neoplasm of uncertain behavior of rectum
D37.8 - Neoplasm of uncertain behavior of other specified digestive organs
D37.9 - Neoplasm of uncertain behavior of digestive organ, unspecified
D3A.092 - Benign carcinoid tumor of the stomach
D3A.098 - Benign carcinoid tumors of other sites
D49.0 - Neoplasm of unspecified behavior of digestive system
F50.010 - Anorexia nervosa, restricting type, mild
F50.011 - Anorexia nervosa, restricting type, moderate
F50.012 - Anorexia nervosa, restricting type, severe
F50.013 - Anorexia nervosa, restricting type, extreme
F50.014 - Anorexia nervosa, restricting type, in remission
F50.019 - Anorexia nervosa, restricting type, unspecified
F50.020 - Anorexia nervosa, binge eating/purging type, mild
F50.021 - Anorexia nervosa, binge eating/purging type, moderate
F50.022 - Anorexia nervosa, binge eating/purging type, severe
F50.023 - Anorexia nervosa, binge eating/purging type, extreme
F50.024 - Anorexia nervosa, binge eating/purging type, in remission
F50.029 - Anorexia nervosa, binge eating/purging type, unspecified
F50.20 - Bulimia nervosa, unspecified
F50.21 - Bulimia nervosa, mild
F50.22 - Bulimia nervosa, moderate
F50.23 - Bulimia nervosa, severe
F50.24 - Bulimia nervosa, extreme
F50.25 - Bulimia nervosa, in remission
F50.810 - Binge eating disorder, mild
F50.811 - Binge eating disorder, moderate
F50.812 - Binge eating disorder, severe
F50.813 - Binge eating disorder, extreme
F50.814 - Binge eating disorder, in remission
F50.819 - Binge eating disorder, unspecified
F50.83 - Pica in adults
F50.84 - Rumination disorder in adults
F98.21 - Rumination disorder of infancy and childhood
K20.0 - Eosinophilic esophagitis
K20.80 - Other esophagitis without bleeding
K20.81 - Other esophagitis with bleeding
K20.90 - Esophagitis, unspecified without bleeding
K20.91 - Esophagitis, unspecified with bleeding
K21.00 - Gastro-esophageal reflux disease with esophagitis, without bleeding
K21.01 - Gastro-esophageal reflux disease with esophagitis, with bleeding
K21.9 - Gastro-esophageal reflux disease without esophagitis
K22.10 - Ulcer of esophagus without bleeding
K22.2 - Esophageal obstruction
K22.4 - Dyskinesia of esophagus
K22.70 - Barrett's esophagus without dysplasia
K22.710 - Barrett's esophagus with low grade dysplasia
K22.711 - Barrett's esophagus with high grade dysplasia
K22.719 - Barrett's esophagus with dysplasia, unspecified
K22.81 - Esophageal polyp
K22.82 - Esophagogastric junction polyp
K22.89 - Other specified disease of esophagus
K23 - Disorders of esophagus in diseases classified elsewhere
K25.2 - Acute gastric ulcer with both hemorrhage and perforation
K31.7 - Polyp of stomach and duodenum
K56.600 - Partial intestinal obstruction, unspecified as to cause
K56.601 - Complete intestinal obstruction, unspecified as to cause
K56.609 - Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction
K59.89 - Other specified functional intestinal disorders
Q85.82 - Other Cowden syndrome
Q85.83 - Von Hippel-Lindau syndrome
Q85.89 - Other phakomatoses, not elsewhere classified
R10.20 - Pelvic and perineal pain unspecified side
R10.21 - Pelvic and perineal pain right side
R10.22 - Pelvic and perineal pain left side
R10.23 - Pelvic and perineal pain bilateral
R10.24 - Suprapubic pain
R10.85 - Abdominal pain of multiple sites
R13.0 - Aphagia
R13.10 - Dysphagia, unspecified
R13.12 - Dysphagia, oropharyngeal phase
R13.13 - Dysphagia, pharyngeal phase
R13.14 - Dysphagia, pharyngoesophageal phase
R13.19 - Other dysphagia
T18.3XXD - Foreign body in small intestine, subsequent encounter
T18.3XXS - Foreign body in small intestine, sequela
T18.8XXD - Foreign body in other parts of alimentary tract, subsequent encounter
T18.9XXD - Foreign body of alimentary tract, part unspecified, subsequent encounter
T18.9XXS - Foreign body of alimentary tract, part unspecified, sequela
T54.1X1D - Toxic effect of other corrosive organic compounds, accidental (unintentional), subsequent encounter
T54.1X1S - Toxic effect of other corrosive organic compounds, accidental (unintentional), sequela
T54.1X2D - Toxic effect of other corrosive organic compounds, intentional self-harm, subsequent encounter
T54.1X2S - Toxic effect of other corrosive organic compounds, intentional self-harm, sequela
T54.1X3D - Toxic effect of other corrosive organic compounds, assault, subsequent encounter
T54.1X3S - Toxic effect of other corrosive organic compounds, assault, sequela
T54.1X4D - Toxic effect of other corrosive organic compounds, undetermined, subsequent encounter
T54.1X4S - Toxic effect of other corrosive organic compounds, undetermined, sequela
T54.2X1D - Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), subsequent encounter
T54.2X1S - Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), sequela
T54.2X2D - Toxic effect of corrosive acids and acid-like substances, intentional self-harm, subsequent encounter
T54.2X2S - Toxic effect of corrosive acids and acid-like substances, intentional self-harm, sequela
T54.2X3D - Toxic effect of corrosive acids and acid-like substances, assault, subsequent encounter
T54.2X3S - Toxic effect of corrosive acids and acid-like substances, assault, sequela
T54.2X4D - Toxic effect of corrosive acids and acid-like substances, undetermined, subsequent encounter
T54.2X4S - Toxic effect of corrosive acids and acid-like substances, undetermined, sequela
T54.3X1D - Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), subsequent encounter
T54.3X1S - Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), sequela
T54.3X2D - Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, subsequent encounter
T54.3X2S - Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, sequela
T54.3X3D - Toxic effect of corrosive alkalis and alkali-like substances, assault, subsequent encounter
T54.3X3S - Toxic effect of corrosive alkalis and alkali-like substances, assault, sequela
T54.3X4D - Toxic effect of corrosive alkalis and alkali-like substances, undetermined, subsequent encounter
T54.3X4S - Toxic effect of corrosive alkalis and alkali-like substances, undetermined, sequela
T54.91XD - Toxic effect of unspecified corrosive substance, accidental (unintentional), subsequent encounter
T54.91XS - Toxic effect of unspecified corrosive substance, accidental (unintentional), sequela
T54.92XD - Toxic effect of unspecified corrosive substance, intentional self-harm, subsequent encounter
T54.92XS - Toxic effect of unspecified corrosive substance, intentional self-harm, sequela
T54.93XD - Toxic effect of unspecified corrosive substance, assault, subsequent encounter
T54.93XS - Toxic effect of unspecified corrosive substance, assault, sequela
T54.94XD - Toxic effect of unspecified corrosive substance, undetermined, subsequent encounter
T54.94XS - Toxic effect of unspecified corrosive substance, undetermined, sequela
T57.1X1D - Toxic effect of phosphorus and its compounds, accidental (unintentional), subsequent encounter
T57.1X1S - Toxic effect of phosphorus and its compounds, accidental (unintentional), sequela
T57.1X2D - Toxic effect of phosphorus and its compounds, intentional self-harm, subsequent encounter
T57.1X2S - Toxic effect of phosphorus and its compounds, intentional self-harm, sequela
T57.1X3D - Toxic effect of phosphorus and its compounds, assault, subsequent encounter
T57.1X3S - Toxic effect of phosphorus and its compounds, assault, sequela
T57.1X4D - Toxic effect of phosphorus and its compounds, undetermined, subsequent encounter
T57.1X4S - Toxic effect of phosphorus and its compounds, undetermined, sequela
T65.5X1D - Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), subsequent encounter
T65.5X1S - Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), sequela
T65.5X2D - Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, subsequent encounter
T65.5X2S - Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, sequela
T65.5X3D - Toxic effect of nitroglycerin and other nitric acids and esters, assault, subsequent encounter
T65.5X3S - Toxic effect of nitroglycerin and other nitric acids and esters, assault, sequela
T65.5X4D - Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, subsequent encounter
T65.5X4S - Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, sequela
Z86.003 - Personal history of in-situ neoplasm of oral cavity, esophagus and stomach
Z86.004 - Personal history of in-situ neoplasm of other and unspecified digestive organs
Related CPT Codes
CPT Codes
43244 - Complete Billing & Coding Guide for EGD with Band Ligation of Esophageal and Gastric Varices
43245 - Complete Billing & Coding Guide for EGD with Dilation of Gastric or Duodenal Strictures
43249 - Complete Billing & Coding Guide for EGD With Esophageal Balloon Dilation
43251 - Complete Billing & Coding Guide for EGD With Snare Removal of Lesions
43254 - Complete Billing & Coding Guide for Endoscopic Mucosal Resection (EMR)
43255 - Complete Billing & Coding Guide for EGD With Control of Bleeding
43239 - Complete Billing & Coding Guide for EGD with Biopsy
43238 - Complete Billing & Coding Guide for EGD with EUS-Guided Fine Needle Aspiration
43235 - Complete Billing & Coding Guide for Diagnostic Esophagogastroduodenoscopy (EGD)